4-Iodo-3-nitrobenzamide
CAS : 160003-66-7
Ref. 3D-FI140420
| 1g | Arrêté | ||
| 2g | Arrêté | ||
| 5g | Arrêté | ||
| 10g | Arrêté | ||
| 500mg | Arrêté |
Informations sur le produit
Nom :
4-Iodo-3-nitrobenzamide
Synonymes :
- AntiPARP-2
- Benzamide, 4-iodo-3-nitro-
- Bsi 201
- Iniparib
- Ino2Ba
- Niba
- Sar240550
- Sml 0623
Description :
Iniparib is a cancer drug that belongs to the class of platinum-based chemotherapy drugs. It inhibits the activity of pro-apoptotic proteins and is used to treat ovarian cancer with low potency. Iniparib has been shown to inhibit the growth of breast cancer cells, as well as other types of cancers. The drug also has an inhibiting effect on metabolic disorders, such as obesity and diabetes, which may be linked to its homologous properties. Iniparib may be useful in treating certain cancers because it has minimal toxicity levels and a low potential for systemic side effects that are common with other chemotherapeutic agents.END>
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
292.03 g/mol
Formule :
C7H5IN2O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
